Indian drug regulator has approved two more Covid-19 vaccines for children opening up the doors for the government to further expand the ongoing vaccination program to the population below 12 years.
Approval has been given to emergency use of Biological E's Covid vaccine Corbevax for children aged five to 12 and Bharat Biotech's Covaxin for six to 12-year olds.
The Corbevax is currently being administered to children in the age group of 12-14. Vaccinations against COVID-19 among minors in India were started from January 3 onwards with those in the 15-18 age group for Bharat Biotech's Covaxin.
The Drugs Controller General of India (DCGI) also approved a two-dose regimen of Zydus Cadila’s ZyCoV-D vaccine for use in 12 plus kids. But the Union Health Ministry is yet to decide whether the indigenous DNA vaccine would be administered to more than 14 crore adolescents, who are now getting Covaxin (15-18 years) and Corbevax (12-14 years).
The approval by the Drugs Controller General of India (DCGI) comes following recommendations by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO).
As per statistics, more than 86% of India’s 93 crore-plus adult population is now fully vaccinated.
Approval has been given to emergency use of Biological E's Covid vaccine Corbevax for children aged five to 12 and Bharat Biotech's Covaxin for six to 12-year olds.
The Corbevax is currently being administered to children in the age group of 12-14. Vaccinations against COVID-19 among minors in India were started from January 3 onwards with those in the 15-18 age group for Bharat Biotech's Covaxin.
The Drugs Controller General of India (DCGI) also approved a two-dose regimen of Zydus Cadila’s ZyCoV-D vaccine for use in 12 plus kids. But the Union Health Ministry is yet to decide whether the indigenous DNA vaccine would be administered to more than 14 crore adolescents, who are now getting Covaxin (15-18 years) and Corbevax (12-14 years).
The approval by the Drugs Controller General of India (DCGI) comes following recommendations by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO).
As per statistics, more than 86% of India’s 93 crore-plus adult population is now fully vaccinated.
